The data is clear: for patients with early stage breast cancer, certain operations risk more harm than good -- increasing the risk of medical complications, missed work and health care costs without increasing survival rates.
A $1.4 million grant from the American Cancer Society will allow a team of researchers led by the University of Michigan Rogel Cancer Center to survey a diverse group of breast cancer patients and their relatives about their experience with genetic testing and their understanding of hereditary cancer risk and prevention.
A U-M Rogel Cancer Center study found aggressive breast cancer cells stored high amounts of energy which enabled them to spread. This suggests a potential target in the metabolism that could slow or prevent breast cancer metastasis.
Recently, the Food and Drug Administration recommended that patients considering breast implants — whether for reconstructive surgery after a mastectomy or cosmetic surgery — receive detailed information about potential complications and rare health risks that can occur.
A new study makes a case for getting screened every year instead of every other year. Women diagnosed with breast cancer after receiving yearly mammograms had smaller tumors and less-advanced disease than women who had mammograms every other year.